Stock Market Cafe
  • Home
  • Trading News
  • Email Whitelisting
  • Privacy Policy
  • Home
  • Trading News
  • Email Whitelisting
  • Privacy Policy
No Result
View All Result
Stock Market Cafe
No Result
View All Result
Home Trading News

Johnson & Johnson Stock Jumps on Reports It Plans to Split In Two

by
November 12, 2021
in Trading News
0
0
SHARES
0
VIEWS
Share on FacebookShare on Twitter
Text size

An entry sign to the Johnson & Johnson campus shows their logo in Irvine, California

Mark Ralston/AFP via Getty Images


Johnson & Johnson

announced plans on Friday to split from its consumer health division, spelling the end of the last great pharmaceutical conglomerate.

Johnson & Johnson (ticker: JNJ) shares were up on the news, which comes two months before a planned CEO transition, in which longtime Johnson & Johnson executive Joaquin Duato is slated to replace Alex Gorsky in the top post.

RELATED POSTS

It’s possible the Jan. 6 committee refers a criminal case against Trump, Liz Cheney says

‘Minions: The Rise of Gru’ tops $108 million as parents flock back to cinemas, kids in tow

Johnson & Johnson said that the split will take 18 to 24 months. The consumer health division, which the company said is expected to generate $15 billion in revenue this year, will become a new publicly traded company, selling big-name brands home health brands like Band-Aid, Tylenol, and Listerine.

The pharmaceutical and medical devices divisions, which the company expects to generate revenue of $77 billion this year, will stay behind as a separate company, selling a range of treatments and devices, from balloons used in sinus procedures to bladder cancer therapies. Johnson & Johnson has chosen not to split those two business segments.

Today, with a market value of $432.5 billion, Johnson & Johnson is the largest pharmaceutical company in the world. Johnson & Johnson says that the stay-behind pharmaceutical and medical device business will remain the biggest pharmaceutical company in the world.

Johnson & Johnson stock was up 4.9% in premarket trading Friday, while

S&P 500
futures had advanced 0.2% and

Dow Jones Industrial Average
futures had risen 0.2%.

Johnson & Johnson has become something of an anachronism in recent years, as its competitors have shed their consumer health divisions one after another.


Pfizer

(PFE) handed its consumer health business to


GlaxoSmithKline

(GSK) in 2019; Glaxo is planning on spinning off the combined business soon.

The market has taken time to warm up to those deals.

Johnson & Johnson would be the third company with plans to break up that were revealed this week. General Electric (GE) said it will break itself up into three parts, while


Toshiba

has said it plans to split up as well.

Write to Ben Levisohn at ben.levisohn@barrons.com

ShareTweetPin

Related Posts

It’s possible the Jan. 6 committee refers a criminal case against Trump, Liz Cheney says

by
July 3, 2022
0

Committee Vice Chair Rep. Liz Cheney (R-WY) listens to testimony from Cassidy Hutchinson, who was an aide to former White...

‘Minions: The Rise of Gru’ tops $108 million as parents flock back to cinemas, kids in tow

by
July 3, 2022
0

In this article CMCSA "Minions: The Rise of Gru" is the sequel to the 2015 film, "Minions," and spin-off/prequel to...

Celsius Customers Are Losing Hope for Their Locked-Up Crypto

by
July 3, 2022
0

When cryptocurrency lending platform Celsius froze user accounts amid a plunge in valuations, it sent ripples across the industry and...

Surging Fuel Costs Are Causing Demand Destruction, Says Vitol

by
July 3, 2022
0

Reuters Analysis: Hasty exit by Argentina's economy minister could deepen market crisis The abrupt departure of Argentina's economy minister and...

If You’ve Got Time, These Three Dividend Aristocrats Should Pay Off

by
July 3, 2022
0

If you're an investor with long time horizon, then you should meet these three high-growth Dividend Aristocrats. Dividend Aristocrats, as...

Next Post

Stocks making the biggest moves premarket: Johnson & Johnson, Rivian, Lordstown and more

J&J plans to split into two companies, separating consumer products and pharmaceutical businesses

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

email

Get the daily email about stock.

Please Enter Your Email Address:

By opting in you agree to our Privacy Policy. You also agree to receive emails from us and our affiliates. Remember that you can opt-out any time, we hate spam too!

MOST VIEWED

  • Crocs sees fourth-quarter sales up 42%, CEO Andrew Rees says 2021 was ‘exceptional year’

    0 shares
    Share 0 Tweet 0
  • Buying a car from the factory sounds expensive, but it can actually save you money. Here’s how to do it.

    0 shares
    Share 0 Tweet 0
  • Roth TSP vs. Roth IRA: How Do They Compare?

    0 shares
    Share 0 Tweet 0
  • The states that won’t tax military retirement in 2022

    0 shares
    Share 0 Tweet 0
  • Allbirds stock has plunged 50% in two months, now one top analyst says buy it

    0 shares
    Share 0 Tweet 0
  • Home
  • Trading News
  • Email Whitelisting
  • Privacy Policy
All rights reserved by www.stockmarket-cafe.com
No Result
View All Result
  • Home
  • Trading News
  • Email Whitelisting
  • Privacy Policy

All rights reserved by www.stockmarket-cafe.com